Pennsylvania Senate Bill SB1067

Pennsylvania 2025-2026 Regular Session

• Introduced: 10/17/25
• Refer: 10/17/25

Caption

In epinephrine auto-injector entities, further providing for definitions and for epinephrine auto-injectors for authorized entities; and making an editorial change.

Impact

The legislation aims to provide clear guidelines regarding the storage, administration, and training surrounding epinephrine delivery systems, which are crucial in responding to life-threatening allergic reactions. By defining authorized entities and requiring staff training, the bill empowers non-medical personnel in places where allergies may occur, ensuring they can respond effectively in emergencies. This impacts day-care facilities significantly, as they are required to follow these new regulations to protect children under their care.

Summary

Senate Bill 1067 amends Title 35 of the Pennsylvania Consolidated Statutes, specifically focusing on epinephrine auto-injector delivery systems for authorized entities, including day-care facilities. The bill facilitates the prescribing and dispensing of epinephrine auto-injectors by health care practitioners and allows authorized entities to stock these injectors for emergency use. This measure is particularly directed at enhancing the preparedness of entities that may encounter individuals experiencing severe allergic reactions, such as anaphylaxis.

Conclusion

Overall, SB1067 seeks to improve emergency preparedness for severe allergies in various settings, emphasizing the importance of training for individuals who may administer medical interventions during such crises. The bill represents a proactive approach to managing allergic reactions in public and care facilities, aiming to create safer environments for vulnerable populations.

Contention

One notable contention surrounding SB1067 is the balance between ensuring safety and managing liability for authorized entities. The bill includes Good Samaritan protections, which shield organizations and their staff from legal repercussions when administering epinephrine in good faith. Opponents may argue that such protections could lead to a lack of accountability or improper usage of epinephrine delivery systems, raising concerns about the adequacy of training provided to staff.